603882.SS
Latest Trade
50.71CNYChange
-0.63(-1.23%)Volume
2,664,621Today's Range
-
51.8952 Week Range
-
62.47As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 51.34 |
|---|---|
Open | 51.45 |
Volume | 2,664,621 |
3M AVG Volume | 93.72 |
Today's High | 51.89 |
Today's Low | 49.90 |
52 Week High | 62.47 |
52 Week Low | 20.49 |
Shares Out (MIL) | 457.88 |
Market Cap (MIL) | 23,507.79 |
Forward P/E | 60.30 |
Dividend (Yield %) | 0.21 |
Guangzhou Kingmed Diagnostics' Shareholders To Unload Up To A Combined 6% Stake
Guangzhou Kingmed Diagnostics' Shareholder To Unload Up To 6% Stake In The Company
Guangzhou Kingmed Diagnostics' Shareholder To Cut Stake In The Company
Guangzhou Kingmed Diagnostics Group Co., Ltd. is a China-based company principally engaged in the medical testing and pathological diagnosis businesses. The Company's main business includes the provision of physical and chemical mass spectrometry, genome testing, pathological diagnosis, biochemical luminescence testing, immunological testing and other comprehensive testing services to various medical institutions. The Company principally operates its businesses in the domestic market.
Industry
Business Services
Executive Leadership
Yaoming Liang
Chairman of the Board, General Manager
Bixi He
Chief Financial Officer, Deputy General Manager, Secretary of the Board, Director
Ting Yan
Deputy General Manager, Director
Price To Earnings (TTM) | 60.58 |
|---|---|
Price To Sales (TTM) | 4.58 |
Price To Book (MRQ) | 10.74 |
Price To Cash Flow (TTM) | -- |
Total Debt To Equity (MRQ) | 30.62 |
LT Debt To Equity (MRQ) | 18.74 |
Return on Investment (TTM) | 15.46 |
Return on Equity (TTM) | 9.66 |
Chinese shares dipped on Wednesday with property developers weighing on broad A-share indexes, as investors' hopes for policy stimulus to overcome a cooling economy faded.
* HK->Shanghai Connect daily quota used 9.5%, Shanghai->HK daily quota used 3.4%
Guangzhou Kingmed Diagnostics Group Co Ltd:
Guangzhou Kingmed Diagnostics Group Co Ltd :
Chinese stocks rose on Tuesday to their highest in nearly three months, as a series of government measures and improving economic data revived investor appetite for riskier assets, but thin volumes indicated that confidence remained fragile.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.